Eisai and Biogen have completed their rolling biologics license application in the US for a subcutaneous formulation of Alzheimer's disease therapy Leqembi previously delayed by the FDA on procedural ...
Anaphylaxis is a severe allergic reaction that can quickly become life threatening. It can affect breathing, digestion, and circulation within seconds of exposure. Symptoms can include wheezing, chest ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results